|
⚲
|
| Keyboard |
| Arkin Bio Ventures Limited Partnership
✚
|
|
|---|---|
| CIK # | 0001808348 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001808348] | |
| 4 | [0001808348] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Keros Therapeutics Inc | |
| Arkin Moshe | |
| Arkin Bio Ventures Limited Partnership | |
| Arkin Bio Venture Partners Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 167,537 | ||
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 343,270 | ||
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Buy | 120,000 | $16.00 | 1,920,000 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 1,382,295 | ||
|
Keros Therapeutics Inc KROS
Series A Preferred Stock · derivative
|
2020-04-13 | Conversion | 1,382,295 | $0.00 | |
|
Keros Therapeutics Inc KROS
Series B-1 Preferred Stock · derivative
|
2020-04-13 | Conversion | 343,270 | $0.00 | |
|
Keros Therapeutics Inc KROS
Series C Preferred Stock · derivative
|
2020-04-13 | Conversion | 167,537 | $0.00 |